Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer

Published:2018-10 Issue:10 Volume:41 Page:977-981
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Hosokawa Ayumu,Ando Takayuki,Ogawa Kohei,Ueda Akira,Yoshita Hiroki,Mihara Hiroshi,Fujinami Haruka,Kajiura Shinya,Yabushita Kazuhisa,Horikawa Naoki,Kobayashi Yuka,Yoshioka Akira,Origasa Hideki,Sugiyama Toshiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference18 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008

3. Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer;Yamaguchi;Br J Cancer,2006

4. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer;Yoshida;Clin Cancer Res,2006

5. Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START);Koizumi;J Cancer Res Clin Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP